Vitality Biopharma Announces International Patent Filing for Cannabinoid Pharmaceuticals

Once concluded, IP protection extends to 2035 or longer in USA and all major markets worldwide LOS ANGELES, CA VBIO, (Marketwired Nov 9, 2016) Vitality Biopharma, Inc. (OTCQB: VBIO) ( Vitality or the Company ), a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of an international PCT patent application, a milestone in its development of a platform of cannabinoid
http://bit.ly/2fZz1oK